Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Phase I/II, Open-label, Study of Intravitreal RAnibizumab 0.5MG, or High Dose 1.0mg for Retinal Vein Occlusions With rEfractory Macular Edema Previously Receiving iNtravitreal Bevacizumab (RAVEN)
Status: Enrolling
Updated:  11/10/2011
South Coast Retina
mi
from
Huntington Beach, CA
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Phase I/II, Open-label, Study of Intravitreal RAnibizumab 0.5MG, or High Dose 1.0mg for Retinal Vein Occlusions With rEfractory Macular Edema Previously Receiving iNtravitreal Bevacizumab (RAVEN)
Status: Enrolling
Updated: 11/10/2011
South Coast Retina
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Phase I/II, Open-label, Study of Intravitreal RAnibizumab 0.5MG, or High Dose 1.0mg for Retinal Vein Occlusions With rEfractory Macular Edema Previously Receiving iNtravitreal Bevacizumab (RAVEN)
Status: Enrolling
Updated:  11/10/2011
South Coast Retina
mi
from
Long Beach, CA
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Phase I/II, Open-label, Study of Intravitreal RAnibizumab 0.5MG, or High Dose 1.0mg for Retinal Vein Occlusions With rEfractory Macular Edema Previously Receiving iNtravitreal Bevacizumab (RAVEN)
Status: Enrolling
Updated: 11/10/2011
South Coast Retina
mi
from
Long Beach, CA
Click here to add this to my saved trials
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Phase I/II, Open-label, Study of Intravitreal RAnibizumab 0.5MG, or High Dose 1.0mg for Retinal Vein Occlusions With rEfractory Macular Edema Previously Receiving iNtravitreal Bevacizumab (RAVEN)
Status: Enrolling
Updated:  11/10/2011
Thomas Hanscom AMC
mi
from
Santa Monica, CA
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Phase I/II, Open-label, Study of Intravitreal RAnibizumab 0.5MG, or High Dose 1.0mg for Retinal Vein Occlusions With rEfractory Macular Edema Previously Receiving iNtravitreal Bevacizumab (RAVEN)
Status: Enrolling
Updated: 11/10/2011
Thomas Hanscom AMC
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Phase I/II, Open-label, Study of Intravitreal RAnibizumab 0.5MG, or High Dose 1.0mg for Retinal Vein Occlusions With rEfractory Macular Edema Previously Receiving iNtravitreal Bevacizumab (RAVEN)
Status: Enrolling
Updated:  11/10/2011
South Coast Retina
mi
from
Torrance, CA
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Phase I/II, Open-label, Study of Intravitreal RAnibizumab 0.5MG, or High Dose 1.0mg for Retinal Vein Occlusions With rEfractory Macular Edema Previously Receiving iNtravitreal Bevacizumab (RAVEN)
Status: Enrolling
Updated: 11/10/2011
South Coast Retina
mi
from
Torrance, CA
Click here to add this to my saved trials
Toronto and Oak Ridge Photobiomodulation Study for Dry Age Related Macular Degeneration
A Pilot Study to Evaluate Clinical Outcomes of Photobiomodulation in Patients With Age Related Macular Degeneration of the Dry Type.
Status: Enrolling
Updated:  11/16/2011
Dr Robert Dotson
mi
from
Oak Ridge, TN
Toronto and Oak Ridge Photobiomodulation Study for Dry Age Related Macular Degeneration
A Pilot Study to Evaluate Clinical Outcomes of Photobiomodulation in Patients With Age Related Macular Degeneration of the Dry Type.
Status: Enrolling
Updated: 11/16/2011
Dr Robert Dotson
mi
from
Oak Ridge, TN
Click here to add this to my saved trials
Toronto and Oak Ridge Photobiomodulation Study for Dry Age Related Macular Degeneration
A Pilot Study to Evaluate Clinical Outcomes of Photobiomodulation in Patients With Age Related Macular Degeneration of the Dry Type.
Status: Enrolling
Updated:  11/16/2011
Dr Graham Merry
mi
from
Toronto,
Toronto and Oak Ridge Photobiomodulation Study for Dry Age Related Macular Degeneration
A Pilot Study to Evaluate Clinical Outcomes of Photobiomodulation in Patients With Age Related Macular Degeneration of the Dry Type.
Status: Enrolling
Updated: 11/16/2011
Dr Graham Merry
mi
from
Toronto,
Click here to add this to my saved trials
Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy
Bromday (Bromfenac Ophthalmic Solution)0.09% QD vs Nevanac (Nepafenac Ophthalmic Suspension) 0.1% TID for Control of Pain and Epithelial Healing Post (PRK)
Status: Enrolling
Updated:  11/20/2011
Virdi Eye Clinic and Laser Vision Center
mi
from
Rock Island, IL
Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy
Bromday (Bromfenac Ophthalmic Solution)0.09% QD vs Nevanac (Nepafenac Ophthalmic Suspension) 0.1% TID for Control of Pain and Epithelial Healing Post (PRK)
Status: Enrolling
Updated: 11/20/2011
Virdi Eye Clinic and Laser Vision Center
mi
from
Rock Island, IL
Click here to add this to my saved trials
Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy
Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy Measured Using The Optical Coherence Tomography (OCT) Scanning Laser Ophthalmoscope (SLO) And The Foresee Preferential Hyperacuity Perimeter
Status: Enrolling
Updated:  12/2/2011
New York Eye & Ear Infirmary
mi
from
New York, NY
Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy
Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy Measured Using The Optical Coherence Tomography (OCT) Scanning Laser Ophthalmoscope (SLO) And The Foresee Preferential Hyperacuity Perimeter
Status: Enrolling
Updated: 12/2/2011
New York Eye & Ear Infirmary
mi
from
New York, NY
Click here to add this to my saved trials
24-hour IOP Fluctuation Profile Recorded With SENSIMED Triggerfish in Primary Open-angle Glaucoma (POAG) Patients After Cataract Surgery
Status: Enrolling
Updated:  12/19/2011
UCSD
mi
from
La Jolla, CA
24-hour IOP Fluctuation Profile Recorded With SENSIMED Triggerfish in Primary Open-angle Glaucoma (POAG) Patients After Cataract Surgery
Status: Enrolling
Updated: 12/19/2011
UCSD
mi
from
La Jolla, CA
Click here to add this to my saved trials
Endophthalmitis Cultures
Prospective Surveillance of Patients With Endophthalmitis for Multi-antibiotic Resistance (PROSPER) Study
Status: Enrolling
Updated:  12/19/2011
Vanderbilt Eye Institute
mi
from
Nashville, TN
Endophthalmitis Cultures
Prospective Surveillance of Patients With Endophthalmitis for Multi-antibiotic Resistance (PROSPER) Study
Status: Enrolling
Updated: 12/19/2011
Vanderbilt Eye Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Proof of Concept Study for First-Sight Refractive Error Correction: Direct Comparison to Manifest Refraction and Autorefraction Results
Proof of Concept Study for First-Sight Refractive Error Correction:Direct Comparison to Manifest Refraction and Autorefraction Results
Status: Enrolling
Updated:  1/9/2012
University of Nebraska Medical Center, Department of Ophthalmology
mi
from
Omaha, NE
Proof of Concept Study for First-Sight Refractive Error Correction: Direct Comparison to Manifest Refraction and Autorefraction Results
Proof of Concept Study for First-Sight Refractive Error Correction:Direct Comparison to Manifest Refraction and Autorefraction Results
Status: Enrolling
Updated: 1/9/2012
University of Nebraska Medical Center, Department of Ophthalmology
mi
from
Omaha, NE
Click here to add this to my saved trials
A Trial in Adults With Type 1 Diabetes Mellitus Evaluating the Effects of Fenofibrate Versus Placebo on Macular Thickness and Volume
The Fenofibrate And Microvascular Event Eye (FAME 1 EYE) Trial: A Randomised Trial in Adults With Type 1 Diabetes Mellitus Evaluating the Effects of Daily Oral Fenofibrate Compared With Placebo on Macular Thickness and Volume
Status: Enrolling
Updated:  1/15/2012
Oklahoma University Health Sciences Center
mi
from
Oklahoma City, OK
A Trial in Adults With Type 1 Diabetes Mellitus Evaluating the Effects of Fenofibrate Versus Placebo on Macular Thickness and Volume
The Fenofibrate And Microvascular Event Eye (FAME 1 EYE) Trial: A Randomised Trial in Adults With Type 1 Diabetes Mellitus Evaluating the Effects of Daily Oral Fenofibrate Compared With Placebo on Macular Thickness and Volume
Status: Enrolling
Updated: 1/15/2012
Oklahoma University Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments
A Prospective, Randomized Study Comparing 1000 Centistoke and 5000 Centistoke Silicone Oil Tamponade for Repair of Proliferative Vitreoretinopathy Retinal Detachments and Diabetic Tractional Retinal Detachments
Status: Enrolling
Updated:  2/8/2012
Wills Eye Institute
mi
from
Philadelphia, PA
Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments
A Prospective, Randomized Study Comparing 1000 Centistoke and 5000 Centistoke Silicone Oil Tamponade for Repair of Proliferative Vitreoretinopathy Retinal Detachments and Diabetic Tractional Retinal Detachments
Status: Enrolling
Updated: 2/8/2012
Wills Eye Institute
mi
from
Philadelphia, PA
Click here to add this to my saved trials
4-Aminopyridine in Episodic Ataxia Type 2
Phase 2 Study of 4-Aminopyridine for the Treatment of Episodic Ataxia Type 2
Status: Enrolling
Updated:  3/8/2012
University of California at Los Angeles - UCLA
mi
from
Los Angeles, CA
4-Aminopyridine in Episodic Ataxia Type 2
Phase 2 Study of 4-Aminopyridine for the Treatment of Episodic Ataxia Type 2
Status: Enrolling
Updated: 3/8/2012
University of California at Los Angeles - UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
4-Aminopyridine in Episodic Ataxia Type 2
Phase 2 Study of 4-Aminopyridine for the Treatment of Episodic Ataxia Type 2
Status: Enrolling
Updated:  3/8/2012
University of South Florida
mi
from
Tampa, FL
4-Aminopyridine in Episodic Ataxia Type 2
Phase 2 Study of 4-Aminopyridine for the Treatment of Episodic Ataxia Type 2
Status: Enrolling
Updated: 3/8/2012
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
4-Aminopyridine in Episodic Ataxia Type 2
Phase 2 Study of 4-Aminopyridine for the Treatment of Episodic Ataxia Type 2
Status: Enrolling
Updated:  3/8/2012
University of Rochester School of Medicine
mi
from
Rochester, NY
4-Aminopyridine in Episodic Ataxia Type 2
Phase 2 Study of 4-Aminopyridine for the Treatment of Episodic Ataxia Type 2
Status: Enrolling
Updated: 3/8/2012
University of Rochester School of Medicine
mi
from
Rochester, NY
Click here to add this to my saved trials
Endogenous Endophthalmitis in the Inpatient Setting
Endogenous Endophthalmitis Rates, Clinical Course, and Outcomes
Status: Enrolling
Updated:  3/22/2012
Stanford University School of Medicine
mi
from
Stanford, CA
Endogenous Endophthalmitis in the Inpatient Setting
Endogenous Endophthalmitis Rates, Clinical Course, and Outcomes
Status: Enrolling
Updated: 3/22/2012
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Oral Nutrition Impact on Tear Film
Eight Week Feasibility Study Enrolling Dry Eye Subjects Confirmed by Four of Seven Dianostic Markers Responding to Nutritional Therapy
Status: Enrolling
Updated:  3/22/2012
Scot Morris
mi
from
Conifer, CO
Oral Nutrition Impact on Tear Film
Eight Week Feasibility Study Enrolling Dry Eye Subjects Confirmed by Four of Seven Dianostic Markers Responding to Nutritional Therapy
Status: Enrolling
Updated: 3/22/2012
Scot Morris
mi
from
Conifer, CO
Click here to add this to my saved trials
Oral Nutrition Impact on Tear Film
Eight Week Feasibility Study Enrolling Dry Eye Subjects Confirmed by Four of Seven Dianostic Markers Responding to Nutritional Therapy
Status: Enrolling
Updated:  3/22/2012
Davis EyeCare
mi
from
Oak Lawn, IL
Oral Nutrition Impact on Tear Film
Eight Week Feasibility Study Enrolling Dry Eye Subjects Confirmed by Four of Seven Dianostic Markers Responding to Nutritional Therapy
Status: Enrolling
Updated: 3/22/2012
Davis EyeCare
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Oral Nutrition Impact on Tear Film
Eight Week Feasibility Study Enrolling Dry Eye Subjects Confirmed by Four of Seven Dianostic Markers Responding to Nutritional Therapy
Status: Enrolling
Updated:  3/22/2012
Koffler Vision Group
mi
from
Lexington, KY
Oral Nutrition Impact on Tear Film
Eight Week Feasibility Study Enrolling Dry Eye Subjects Confirmed by Four of Seven Dianostic Markers Responding to Nutritional Therapy
Status: Enrolling
Updated: 3/22/2012
Koffler Vision Group
mi
from
Lexington, KY
Click here to add this to my saved trials
Oral Nutrition Impact on Tear Film
Eight Week Feasibility Study Enrolling Dry Eye Subjects Confirmed by Four of Seven Dianostic Markers Responding to Nutritional Therapy
Status: Enrolling
Updated:  3/22/2012
Sean Mulqueeny OD
mi
from
Creve Coeur, MO
Oral Nutrition Impact on Tear Film
Eight Week Feasibility Study Enrolling Dry Eye Subjects Confirmed by Four of Seven Dianostic Markers Responding to Nutritional Therapy
Status: Enrolling
Updated: 3/22/2012
Sean Mulqueeny OD
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment
Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment
Status: Enrolling
Updated:  3/27/2012
Illinois Retina Associates
mi
from
Oak Park, IL
Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment
Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment
Status: Enrolling
Updated: 3/27/2012
Illinois Retina Associates
mi
from
Oak Park, IL
Click here to add this to my saved trials
Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations
Phase 1b Study to Evaluate QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT)
Status: Enrolling
Updated:  4/5/2012
The Chicago Lighthouse for People Who Are Blind or Visually Impaired (The Pangere Center For Inherited Retinal Diseases)
mi
from
Chicago, IL
Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations
Phase 1b Study to Evaluate QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT)
Status: Enrolling
Updated: 4/5/2012
The Chicago Lighthouse for People Who Are Blind or Visually Impaired (The Pangere Center For Inherited Retinal Diseases)
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations
Phase 1b Study to Evaluate QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT)
Status: Enrolling
Updated:  4/5/2012
Wilmer Eye Institute, Johns Hopkins University
mi
from
Baltimore, MD
Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations
Phase 1b Study to Evaluate QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT)
Status: Enrolling
Updated: 4/5/2012
Wilmer Eye Institute, Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations
Phase 1b Study to Evaluate QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT)
Status: Enrolling
Updated:  4/5/2012
Scheie Eye Institute
mi
from
Philadelphia, PA
Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations
Phase 1b Study to Evaluate QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT)
Status: Enrolling
Updated: 4/5/2012
Scheie Eye Institute
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety Study in Retinal Transplantation for Retinitis Pigmentosa.
Safety Study in Retinal Transplantation for Retinitis Pigmentosa.
Status: Enrolling
Updated:  4/10/2012
Retina Vitreous Resource Center
mi
from
Louisville, KY
Safety Study in Retinal Transplantation for Retinitis Pigmentosa.
Safety Study in Retinal Transplantation for Retinitis Pigmentosa.
Status: Enrolling
Updated: 4/10/2012
Retina Vitreous Resource Center
mi
from
Louisville, KY
Click here to add this to my saved trials
Efficacy of Changing to DuoTrav From Prior Therapy
Assessing the Efficacy and Tolerability of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination), as Replacement Therapy in Patients Previously on Bimatoprost 0.03%/Timolol 0.5% Therapy (Fixed or Unfixed)
Status: Enrolling
Updated:  4/12/2012
Alcon Call Center
mi
from
Fort Worth, TX
Efficacy of Changing to DuoTrav From Prior Therapy
Assessing the Efficacy and Tolerability of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination), as Replacement Therapy in Patients Previously on Bimatoprost 0.03%/Timolol 0.5% Therapy (Fixed or Unfixed)
Status: Enrolling
Updated: 4/12/2012
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.
Efficacy of an Intravitreal Dexamethasone Implant on Macular Function in Retinal Vein Occlusion Following Treatment With Intravitreal Anti-VEGF Injections.
Status: Enrolling
Updated:  4/13/2012
Retina Macula Institute
mi
from
Torrance, CA
Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.
Efficacy of an Intravitreal Dexamethasone Implant on Macular Function in Retinal Vein Occlusion Following Treatment With Intravitreal Anti-VEGF Injections.
Status: Enrolling
Updated: 4/13/2012
Retina Macula Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
Near-infrared Light (NIR) Therapy for Diabetic Macular Edema: A Pilot Study
Phase 1 Study To Determine the Effects of Short Term Near-infrared Light (NIR) Therapy on Anatomic and Functional Abnormalities of Diabetic Macular Edema, and Assess Safety of Short Term Near-infrared Light Therapy in Eyes With Diabetic Macular Edema.
Status: Enrolling
Updated:  4/18/2012
Medical College of Wisconsin
mi
from
Milwaukee, WI
Near-infrared Light (NIR) Therapy for Diabetic Macular Edema: A Pilot Study
Phase 1 Study To Determine the Effects of Short Term Near-infrared Light (NIR) Therapy on Anatomic and Functional Abnormalities of Diabetic Macular Edema, and Assess Safety of Short Term Near-infrared Light Therapy in Eyes With Diabetic Macular Edema.
Status: Enrolling
Updated: 4/18/2012
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)
Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated:  4/18/2012
Medical College of Wisconsin
mi
from
Milwaukee, WI
Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)
Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated: 4/18/2012
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)
Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated:  4/18/2012
The Eye Institute
mi
from
Milwaukee, WI
Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)
Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated: 4/18/2012
The Eye Institute
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)
Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated:  4/18/2012
Froedtert Memorial Lutheran Hospital
mi
from
Milwaukee, WI
Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)
Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated: 4/18/2012
Froedtert Memorial Lutheran Hospital
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Effect of Cosopt Versus Combigan on Retinal Vascular Autoregulation in Primary Open Angle Glaucoma (POAG)
Status: Enrolling
Updated:  4/19/2012
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
Effect of Cosopt Versus Combigan on Retinal Vascular Autoregulation in Primary Open Angle Glaucoma (POAG)
Status: Enrolling
Updated: 4/19/2012
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
Click here to add this to my saved trials
The Effects of Caffeinated Coffee on Intraocular Pressure
The Effects of Caffeinated Coffee on Intraocular Pressure
Status: Enrolling
Updated:  4/19/2012
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
The Effects of Caffeinated Coffee on Intraocular Pressure
The Effects of Caffeinated Coffee on Intraocular Pressure
Status: Enrolling
Updated: 4/19/2012
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Retina Consultants of Arizona
mi
from
Phoenix, AZ
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Retina Consultants of Arizona
mi
from
Phoenix, AZ
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Retina Vitreous Associates
mi
from
Beverly Hills, CA
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Retina Vitreous Associates
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Center for Retina and Macular Disease
mi
from
Winter Haven, FL
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Center for Retina and Macular Disease
mi
from
Winter Haven, FL
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Thomas A. Cuilla, MD, PC at Midwest Eye Institute
mi
from
Indianapolis, IN
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Thomas A. Cuilla, MD, PC at Midwest Eye Institute
mi
from
Indianapolis, IN
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Eyesight Ophthalmic Services, PA
mi
from
Portsmouth, NH
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Eyesight Ophthalmic Services, PA
mi
from
Portsmouth, NH
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Retina Vitreous Center
mi
from
Toms River, NJ
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Retina Vitreous Center
mi
from
Toms River, NJ
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Southeast Clinical Research Associates, LLC
mi
from
Charlotte, NC
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Southeast Clinical Research Associates, LLC
mi
from
Charlotte, NC
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Black Hills Regioinal Eye Institute
mi
from
Rapid City, SD
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Black Hills Regioinal Eye Institute
mi
from
Rapid City, SD
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Retinal Consultants of Houston
mi
from
Houston, TX
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Retinal Consultants of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Valley Retina Institute
mi
from
Harlingen, TX
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Valley Retina Institute
mi
from
Harlingen, TX
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Retinal Consultants of San Antonio
mi
from
San Antonio, TX
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Retinal Consultants of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
OCT-guided DSAEK Graft Shaping and Smoothing
Randomized Clinical Trial of OCT-guided DSAEK Graft Shaping and Smoothing
Status: Enrolling
Updated:  4/24/2012
Devers Eye Insitute
mi
from
Portland, OR
OCT-guided DSAEK Graft Shaping and Smoothing
Randomized Clinical Trial of OCT-guided DSAEK Graft Shaping and Smoothing
Status: Enrolling
Updated: 4/24/2012
Devers Eye Insitute
mi
from
Portland, OR
Click here to add this to my saved trials
Investigating the Effects of Evening Light Exposure on Melatonin Suppression, Alertness and Nocturnal Sleep
Investigating the Effects of Evening Light Exposure on Melatonin Suppression, Alertness and Nocturnal Sleep.
Status: Enrolling
Updated:  4/25/2012
Brigham and Women's Hosp
mi
from
Boston, MA
Investigating the Effects of Evening Light Exposure on Melatonin Suppression, Alertness and Nocturnal Sleep
Investigating the Effects of Evening Light Exposure on Melatonin Suppression, Alertness and Nocturnal Sleep.
Status: Enrolling
Updated: 4/25/2012
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Patient Satisfaction and Tear Osmolarity With the Use of Blink Tears, Blink Gel Tears and Systane Balance
Phase 4 Study Accessing Patient Satisfaction and Tear Osmolarity While Using Blink Tears, Blink Gel Tears and Systane Balance
Status: Enrolling
Updated:  5/1/2012
Ophthalmic Consultants of Connecticut
mi
from
Fairfield, CT
Patient Satisfaction and Tear Osmolarity With the Use of Blink Tears, Blink Gel Tears and Systane Balance
Phase 4 Study Accessing Patient Satisfaction and Tear Osmolarity While Using Blink Tears, Blink Gel Tears and Systane Balance
Status: Enrolling
Updated: 5/1/2012
Ophthalmic Consultants of Connecticut
mi
from
Fairfield, CT
Click here to add this to my saved trials
First-Sight Refractive Error Correction in the Developing World
First-Sight Refractive Error Correction in the Developing World
Status: Archived
Updated:  5/14/2012
University of Nebraska Medical Center, Department of Ophthalmology
mi
from
Omaha, NE
First-Sight Refractive Error Correction in the Developing World
First-Sight Refractive Error Correction in the Developing World
Status: Archived
Updated: 5/14/2012
University of Nebraska Medical Center, Department of Ophthalmology
mi
from
Omaha, NE